About RBC Life Sciences
RBC Life Sciences, Inc. is engaged in the marketing and distribution of nutritional supplements and personal care products. The Company markets its product line under the RBC Life brand name. The Company's product line includes herbal formulas, vitamins, minerals, antioxidants and skin, hair and body care products. The Company operates in two segments: Nutritional Products and Medical Products. Its Nutritional Products segment distributes products in three categories: wellness products, fitness products and skin care products. The Company's Medical Products segment distributes wound care products. It markets nutritional products in North America, Southeast Asia and Australia through a network of independent distributors. It also markets a line of wound care products through a subsidiary under the MPM Medical brand name. Medical Products are primarily distributed in the United States to hospitals, nursing homes, clinics and pharmacies.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: N/A
- Sub-Industry: N/A
- Exchange: OTCMKTS
- Symbol: RBCL
- CUSIP:
Key Metrics:
- Previous Close: $0.00
- 50 Day Moving Average: $
- 200 Day Moving Average: $
- 52-Week Range: $2,212,000.00 - $0.10
- Trailing P/E Ratio:
- P/E Growth:
- Market Cap: $
- Outstanding Shares: 2,212,000
- Beta: -0.57
Additional Links:
Companies Related to RBC Life Sciences:
Consensus Ratings for RBC Life Sciences (OTCMKTS:RBCL) (?) The ratings breakdown includes the most recent rating from each analyst that has rated the stock within the last twelve months. The ratings score is a calculation of the average number of sell, hold, buy and strong buy ratings (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). The consensus price target is a mean average of the most recent price target set by each analyst that has set a price target for the stock in the last twelve months.| Ratings Breakdown: | No ratings tracked in the last 12 months. |
| Consensus Rating: | N/A (Score: NaN) |
| Consensus Price Target: | N/A |
Analysts' Ratings History for RBC Life Sciences (OTCMKTS:RBCL)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com
Earnings History for RBC Life Sciences (OTCMKTS:RBCL)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for RBC Life Sciences (OTCMKTS:RBCL)
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for RBC Life Sciences (OTCMKTS:RBCL)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for RBC Life Sciences (OTCMKTS:RBCL)Insider Ownership Percentage: 45.80%
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 6/16/2014 | Clinton H Howard | CEO | Buy | 5,000 | $0.60 | $3,000.00 |  |
| 6/2/2014 | Clinton H Howard | CEO | Buy | 3,100 | $0.60 | $1,860.00 | |
(Data available from 1/1/2013 forward)
Headlines for RBC Life Sciences (OTCMKTS:RBCL)
No headlines for this company have been tracked by MarketBeat.com
RBC Life Sciences (OTCMKTS:RBCL) Chart for Tuesday, September, 27, 2016
